{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:09:30Z","timestamp":1793362170112,"version":"4.5.0"},"reference-count":320,"publisher":"Oxford University Press (OUP)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12,1]]},"DOI":"10.1093\/eurheartj\/ehr236","type":"journal-article","created":{"date-parts":[[2011,8,27]],"date-time":"2011-08-27T00:46:26Z","timestamp":1314405986000},"page":"2999-3054","source":"Crossref","is-referenced-by-count":2640,"title":["ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation"],"prefix":"10.1093","volume":"32","author":[{"name":"Authors\/Task Force Members","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bassand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Agewall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pio","family":"Caso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dariusz","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Ohman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Sonntag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Sousa","family":"Uva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Storey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Wijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Zahger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ESC Committee for Practice Guidelines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J.","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ceconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Dean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christi","family":"Deaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Funck-Brentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hasdai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhani","family":"Knuuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Kolh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don","family":"Poldermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan A.","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo","family":"Sechtem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Anton","family":"Sirnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Torbicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alec","family":"Vahanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Document Reviewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Windecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Erik","family":"B\u00f8tker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Collet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erling","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Goudevenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Gulba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hambrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keld","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Dalby","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizio","family":"Lancellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julinda","family":"Mehilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Montalescot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz-Josef","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludwig","family":"Neyses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep","family":"Perk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Roffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail","family":"Ruda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Swahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiaan JM","family":"Vrints","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,8,26]]},"reference":[{"key":"2026080919360214300_EHR236C1","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C2","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C3","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C4","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C5","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1136\/hrt.2009.190827","article-title":"The Global Registry of Acute Coronary Events, 1999 to 2009\u2014GRACE","volume":"96","author":"Fox","year":"2010","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jama.281.8.707","article-title":"Prognostic value of the admission electrocardiogram in acute coronary syndromes","volume":"281","author":"Savonitto","year":"1999","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C7","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehi002","article-title":"Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort","volume":"26","author":"Terkelsen","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C9","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780199566990.003.016","article-title":"Acute coronary syndrome","volume-title":"The ESC Textbook of Cardiovascular Medicine","author":"Hamm","year":"2009","edition":"2nd"},{"key":"2026080919360214300_EHR236C10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/circ.54.3.947585","article-title":"Grading of angina pectoris","volume":"54","author":"Campeau","year":"1976","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/S0735-1097(98)00140-5","article-title":"Unstable angina: good long-term outcome after a complicated early course","volume":"31","author":"van Domburg RT, van Miltenburg-van Zijl AJ, Veerhoek RJ, Simoons ML","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0002-9149(02)02463-3","article-title":"Atypical presentations among Medicare beneficiaries with unstable angina pectoris","volume":"90","author":"Canto","year":"2002","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C14","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1067\/mhj.2002.125625","article-title":"Symptom presentation of acute myocardial infarction: influence of sex, age, and risk factors","volume":"144","author":"Culic","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1378\/chest.126.2.461","article-title":"Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events","volume":"126","author":"Brieger","year":"2004","journal-title":"Chest"},{"key":"2026080919360214300_EHR236C16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0002-9149(02)03111-9","article-title":"Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns","volume":"91","author":"Lev","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amjcard.2005.09.073","article-title":"Frequency and consequences of recording an electrocardiogram &gt;10 min after arrival in an emergency room in non-ST-segment elevation acute coronary syndromes (from the CRUSADE Initiative)","volume":"97","author":"Diercks","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C18","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/01.CIR.0000109696.92474.92","article-title":"Elevated troponin T levels and lesion characteristics in non-ST-elevation acute coronary syndromes","volume":"109","author":"Okamatsu","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1056\/NEJMoa0903515","article-title":"Sensitive troponin I assay in early diagnosis of acute myocardial infarction","volume":"361","author":"Keller","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C22","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1373\/clinchem.2009.134460","article-title":"High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission","volume":"56","author":"Giannitsis","year":"2010","journal-title":"Clin Chem"},{"key":"2026080919360214300_EHR236C23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ahj.2011.04.007","article-title":"Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome","volume":"162","author":"Weber","year":"2011","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C24","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","article-title":"A sensitive cardiac troponin T assay in stable coronary artery disease","volume":"361","author":"Omland","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C25","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2010.1768","article-title":"Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population","volume":"304","author":"de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK","year":"2010","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C26","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.ahj.2010.02.036","article-title":"Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease","volume":"159","author":"Otsuka","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C27","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","article-title":"Recommendations for the use of cardiac troponin measurement in acute cardiac care","volume":"31","author":"Thygesen","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C28","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000041254.30637.34","article-title":"Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease","volume":"106","author":"Apple","year":"2002","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C29","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1056\/NEJMoa013456","article-title":"Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction","volume":"346","author":"Aviles","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C30","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1056\/NEJM199712043372302","article-title":"Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I","volume":"337","author":"Hamm","year":"1997","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/clinchem\/45.7.1104","article-title":"National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases","volume":"45","author":"Wu","year":"1999","journal-title":"Clin Chem"},{"key":"2026080919360214300_EHR236C32","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(11)60310-3","article-title":"A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study","volume":"377","author":"Than","year":"2011","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/01.CIR.0000073597.57414.A9","article-title":"ACC\/AHA\/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)","volume":"108","author":"Cheitlin","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C34","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.amjcard.2007.05.027","article-title":"Comparison of early dobutamine stress echocardiography and exercise electrocardiographic testing for management of patients presenting to the emergency department with chest pain","volume":"100","author":"Nucifora","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C35","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.CIR.0000047527.11221.29","article-title":"Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging","volume":"107","author":"Kwong","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C36","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.288.21.2693","article-title":"Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial","volume":"288","author":"Udelson","year":"2002","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C37","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jacc.2009.01.052","article-title":"Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial","volume":"53","author":"Hoffmann","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C38","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1161\/CIRCULATIONAHA.106.618389","article-title":"Usefulness of 64-slice cardiac computed tomographic angiography for diagnosing acute coronary syndromes and predicting clinical outcome in emergency department patients with chest pain of uncertain origin","volume":"115","author":"Rubinshtein","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1136\/hrt.2006.112771","article-title":"64-Slice CT coronary angiography in patients with non-ST elevation acute coronary syndrome","volume":"93","author":"Meijboom","year":"2007","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1553-2712.2009.00459.x","article-title":"One-year outcomes following coronary computerized tomographic angiography for evaluation of emergency department patients with potential acute coronary syndrome","volume":"16","author":"Hollander","year":"2009","journal-title":"Acad Emerg Med"},{"key":"2026080919360214300_EHR236C41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ahj.2008.03.016","article-title":"Usefulness of 64-slice multidetector computed tomography as an initial diagnostic approach in patients with acute chest pain","volume":"156","author":"Chang","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C42","first-page":"1545","article-title":"Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C43","first-page":"708","article-title":"FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators","volume":"354","author":"Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","year":"1999","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention","volume":"360","author":"Tonino","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C45","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0140-6736(11)60404-2","article-title":"Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial","volume":"377","author":"Jolly","year":"2011","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0195-668X(02)00742-X","article-title":"Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: lessons from the Euro-Heart Survey of acute coronary syndromes","volume":"24","author":"Hasdai","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C47","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/eurheartj\/ehi202","article-title":"Recommendations for the structure, organization, and operation of intensive cardiac care units","volume":"26","author":"Hasin","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C48","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the global registry of acute coronary events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"2026080919360214300_EHR236C49","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.38985.646481.55","article-title":"Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)","volume":"333","author":"Fox","year":"2006","journal-title":"BMJ"},{"key":"2026080919360214300_EHR236C51","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/eurheartj\/ehq504","article-title":"Acute coronary syndrome and cocaine use: 8-year prevalence and inhospital outcomes","volume":"32","author":"Carrillo","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0735-1097(02)02970-4","article-title":"Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment","volume":"41","author":"Holmvang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0735-1097(01)01307-9","article-title":"Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb\/IIIa Antagonism for the Reduction of Acute Global Organization Network","volume":"38","author":"Kaul","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0167-5273(93)90024-B","article-title":"Risk stratification by early exercise testing after an episode of unstable coronary artery disease. The RISC Study Group","volume":"39","author":"Nyman","year":"1993","journal-title":"Int J Cardiol"},{"key":"2026080919360214300_EHR236C55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0735-1097(02)01968-X","article-title":"Immediate exercise testing to evaluate low-risk patients presenting to the emergency department with chest pain","volume":"40","author":"Amsterdam","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C56","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2008.12.053","article-title":"Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial","volume":"53","author":"Scirica","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C57","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1053\/euhj.2001.2750","article-title":"Recurrent ischaemia during continuous multilead ST-segment monitoring identifies patients with acute coronary syndromes at high risk of adverse cardiac events; meta-analysis of three studies involving 995 patients","volume":"22","author":"Akkerhuis","year":"2001","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C58","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199610313351802","article-title":"Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes","volume":"335","author":"Antman","year":"1996","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.ahj.2010.07.022","article-title":"Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: an undertreated but high-risk patient group: results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network\u2014Get With The Guidelines (NCDR ACTION-GWTG) Registry","volume":"160","author":"Kontos","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1161\/01.CIR.0000079170.10579.DC","article-title":"N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy","volume":"108","author":"James","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C61","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.amjmed.2008.07.029","article-title":"Risk stratification in non-ST-segment elevation acute coronary syndromes: troponin alone is not enough","volume":"122","author":"Steg","year":"2009","journal-title":"Am J Med"},{"key":"2026080919360214300_EHR236C62","article-title":"Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care","author":"Thygesen","year":"2011","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C63","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial","volume":"35","author":"Heeschen","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C64","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction","volume":"31","author":"Morrow","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C65","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease","volume":"343","author":"Lindahl","year":"2000","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/hrt.2007.118794","article-title":"Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality","volume":"94","author":"Currie","year":"2008","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C67","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.amjcard.2009.05.053","article-title":"Usefulness of changes in fasting glucose during hospitalization to predict long-term mortality in patients with acute myocardial infarction","volume":"104","author":"Aronson","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.0000155235.48601.2A","article-title":"Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study","volume":"111","author":"Suleiman","year":"2005","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C69","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C70","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-007-0498-4","article-title":"Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial","volume":"23","author":"Mahaffey","year":"2008","journal-title":"J Gen Intern Med"},{"key":"2026080919360214300_EHR236C71","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/01.CIR.0000027560.41358.B3","article-title":"Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes","volume":"106","author":"Al Suwaidi","year":"2002","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C72","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.0000090690.67322.51","article-title":"Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes","volume":"108","author":"Baldus","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C73","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C74","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/CIRCULATIONAHA.106.650846","article-title":"Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome","volume":"115","author":"Wollert","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C75","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehn071","article-title":"Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18","volume":"29","author":"Morrow","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C76","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1016\/j.jacc.2009.12.062","article-title":"Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative","volume":"55","author":"Viswanathan","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C77","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ahj.2009.12.026","article-title":"Ischemia-modified albumin levels predict long-term outcome in patients with acute myocardial infarction. The French Nationwide OPERA study","volume":"159","author":"Van Belle","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C78","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2009.01.076","article-title":"Incremental value of copeptin for rapid rule out of acute myocardial infarction","volume":"54","author":"Reichlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C79","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/eurheartj\/ehi187","article-title":"TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS","volume":"26","author":"de Araujo Goncalves P, Ferreira J, Aguiar C, Seabra-Gomes R","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C80","doi-asserted-by":"crossref","first-page":"e7947","DOI":"10.1371\/journal.pone.0007947","article-title":"Does simplicity compromise accuracy in ACS risk prediction? A retrospective analysis of the TIMI and GRACE risk scores","volume":"4","author":"Aragam","year":"2009","journal-title":"PLoS One"},{"key":"2026080919360214300_EHR236C81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ahj.2010.05.002","article-title":"Improving long-term risk prediction in patients with acute chest pain: the Global Registry of Acute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers","volume":"160","author":"Eggers","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C82","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1001\/jama.290.16.2174","article-title":"Prognostic importance of physical examination for heart failure in non-ST-elevation acute coronary syndromes: the enduring value of Killip classification","volume":"290","author":"Khot","year":"2003","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C83","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C84","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C85","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0033-0620(85)80003-7","article-title":"Beta blockade during and after myocardial infarction: an overview of the randomized trials","volume":"27","author":"Yusuf","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"2026080919360214300_EHR236C86","first-page":"57","article-title":"First International Study of Infarct Survival Collaborative Group","volume":"2","author":"Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1","year":"1986","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C87","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(81)92399-0","article-title":"Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome","volume":"1","author":"Telford","year":"1981","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C88","doi-asserted-by":"crossref","first-page":"18A","DOI":"10.1016\/0002-9149(87)90494-2","article-title":"Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine\/metoprolol Trial (HINT)","volume":"60","author":"Lubsen","year":"1987","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C89","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.1988.03410140100032","article-title":"Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction","volume":"260","author":"Yusuf","year":"1988","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C90","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/oxfordjournals.eurheartj.a061845","article-title":"A randomised placebo-controlled international trial. The MIAMI Trial Research Group","volume":"6","author":"Metoprolol in acute myocardial infarction (MIAMI)","year":"1985","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C91","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjmed.2007.04.016","article-title":"Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction","volume":"120","author":"Miller","year":"2007","journal-title":"Am J Med"},{"key":"2026080919360214300_EHR236C92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1553-2712.2009.00625.x","article-title":"Does the early administration of beta-blockers improve the in-hospital mortality rate of patients admitted with acute coronary syndrome?","volume":"17","author":"Brandler","year":"2010","journal-title":"Acad Emerg Med"},{"key":"2026080919360214300_EHR236C93","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C94","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0002-9149(97)01006-0","article-title":"Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia","volume":"81","author":"Borzak","year":"1998","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C95","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/eurheartj\/ehp457","article-title":"Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events","volume":"31","author":"Ambrosio","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C96","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0735-6757(98)90087-0","article-title":"High-dose nitrates in the immediate management of unstable angina: optimal dosage, route of administration, and therapeutic goals","volume":"16","author":"Cotter","year":"1998","journal-title":"Am J Emerg Med"},{"key":"2026080919360214300_EHR236C97","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0735-1097(85)80400-9","article-title":"A randomized study comparing propranolol and diltiazem in the treatment of unstable angina","volume":"5","author":"Theroux","year":"1985","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C98","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/0002-9149(86)90727-7","article-title":"Comparison of verapamil and propranolol therapy for angina pectoris at rest: a randomized, multiple-crossover, controlled trial in the coronary care unit","volume":"57","author":"Parodi","year":"1986","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C99","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2165\/00003495-199100422-00008","article-title":"Treatment with verapamil after an acute myocardial infarction. Review of the Danish studies on verapamil in myocardial infarction (DAVIT I and II)","volume":"42 Suppl 2","author":"Hansen","year":"1991","journal-title":"Drugs"},{"key":"2026080919360214300_EHR236C100","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9149(91)90773-E","article-title":"Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group","volume":"68","author":"Moss","year":"1991","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C101","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(02)08265-X","article-title":"Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.phrs.2006.03.017","article-title":"Therapeutic effects of I(f) blockade: evidence and perspective","volume":"53","author":"Borer","year":"2006","journal-title":"Pharmacol Res"},{"key":"2026080919360214300_EHR236C103","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C104","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C105","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.88.5.2045","article-title":"Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina","volume":"88","author":"Theroux","year":"1993","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C106","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM198511283132201","article-title":"Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial","volume":"313","author":"Cairns","year":"1985","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C107","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C108","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C109","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C111","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/01.CIR.0000051362.96946.15","article-title":"Early and late effects of clopidogrel in patients with acute coronary syndromes","volume":"107","author":"Yusuf","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C112","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.299.5.532","article-title":"Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome","volume":"299","author":"Ho","year":"2008","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C113","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","article-title":"Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial","volume":"110","author":"Fox","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C114","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2006.04.090","article-title":"A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) Trial","volume":"48","author":"Montalescot","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ahj.2007.04.014","article-title":"Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis","volume":"154","author":"Snoep","year":"2007","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C116","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jcin.2008.09.004","article-title":"Clopidogrel 150 mg\/day to overcome low responsiveness in patients undergoing elective percutaneous coronary intervention: results from the VASP-02 (Vasodilator-Stimulated Phosphoprotein-02) Randomized Study","volume":"1","author":"Aleil","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919360214300_EHR236C117","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"The CURRENT-OASIS 7 Investigators","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C118","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clpt.2006.07.007","article-title":"Impact of P-glycoprotein on clopidogrel absorption","volume":"80","author":"Taubert","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"2026080919360214300_EHR236C119","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(10)61273-1","article-title":"Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis","volume":"376","author":"Mega","year":"2010","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C120","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega","year":"2010","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C121","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2010.181","article-title":"Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation","volume":"303","author":"Breet","year":"2010","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C122","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C123","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jacc.2007.12.056","article-title":"Cytochrome P450 2C19 681G&gt;A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents","volume":"51","author":"Trenk","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C124","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0140-6736(09)61525-7","article-title":"Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials","volume":"374","author":"O'Donoghue","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C126","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1161\/CIR.0b013e318202f701","article-title":"ACCF\/ACG\/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents","volume":"122","author":"Abraham","year":"2010","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C127","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","article-title":"Clopidogrel with or without omeprazole in coronary artery disease","volume":"363","author":"Bhatt","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C128","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/CIRCULATIONAHA.107.740324","article-title":"Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation Thrombolysis in Myocardial Infarction 44 Trial","volume":"116","author":"Wiviott","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","article-title":"Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel","volume":"48","author":"Small","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"2026080919360214300_EHR236C130","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C131","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSet of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET Study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C132","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C133","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(09)62191-7","article-title":"Ticagrelor compared with clopidogrel in acute coronary syndromes patients with a planned invasive strategy (PLATO): a randomised double-blind study","volume":"375","author":"Cannon","year":"2010","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C134","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery results from the PLATO (Platelet Inhibition and Patient Outcomes) Trial","volume":"57","author":"Held","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C135","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C136","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","article-title":"Safety, tolerability, and initial efficacy of AZD6140, the First reversible oral adenosine diphosphate receptor antagonist, compared with clopidogrel, in patients with non-ST-segment elevation acute coronary syndrome: primary results of the DISPERSE-2 Trial","volume":"50","author":"Cannon","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C137","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jacc.2010.01.062","article-title":"Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel or placebo in the ONSET\/OFFSET Study","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C138","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2008.08.031","article-title":"Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis","volume":"52","author":"Berger","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C139","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/eurheartj\/ehi074","article-title":"Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?","volume":"26","author":"Kapetanakis","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jacc.2006.04.029","article-title":"Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery","volume":"48","author":"Mehta","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C141","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jacc.2009.03.006","article-title":"Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial","volume":"53","author":"Ebrahimi","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C142","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ahj.2008.06.034","article-title":"Clopidogrel use and bleeding after coronary artery bypass graft surgery","volume":"156","author":"Kim","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C143","first-page":"683","article-title":"Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: a position statement of the Canadian Cardiovascular Society","volume":"25","author":"Fitchett","year":"2009","journal-title":"Can J Cardiol"},{"key":"2026080919360214300_EHR236C144","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1161\/01.CIR.0000145171.89690.B4","article-title":"Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes","volume":"110","author":"Collet","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C145","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/CIRCULATIONAHA.106.180944","article-title":"Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians","volume":"115","author":"Grines","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C146","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C147","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C148","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","article-title":"Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C149","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1053\/euhj.2002.3160","article-title":"Platelet glycoprotein IIb\/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularisation strategy","volume":"23","author":"Roffi","year":"2002","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C150","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C151","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C152","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/jama.295.13.joc60034","article-title":"Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 Randomized Trial","volume":"295","author":"Kastrati","year":"2006","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C153","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/mhj.2000.107554","article-title":"Thrombocytopenia complicating treatment with intravenous glycoprotein IIb\/IIIa receptor inhibitors: a pooled analysis","volume":"140","author":"Dasgupta","year":"2000","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C154","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(199907)61:3<205::AID-AJH8>3.0.CO;2-9","article-title":"Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy","volume":"61","author":"Jubelirer","year":"1999","journal-title":"Am J Hematol"},{"key":"2026080919360214300_EHR236C155","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1160\/TH09-08-0603","article-title":"Thrombocytopenia after abciximab use results from different mechanisms","volume":"103","author":"Lajus","year":"2010","journal-title":"Thromb Haemost"},{"key":"2026080919360214300_EHR236C156","first-page":"436","article-title":"The PURSUIT Trial Investigators. Platelet glycoprotein IIb\/IIIa in unstable angina: receptor suppression using integrilin therapy","volume":"339","author":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","year":"1998","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C157","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1161\/01.CIR.0000127867.41621.85","article-title":"Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting","volume":"109","author":"Merlini","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C158","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM200106213442502","article-title":"Comparison of two platelet glycoprotein IIb\/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization","volume":"344","author":"Topol","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C159","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(02)09605-8","article-title":"Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study","volume":"360","author":"Moliterno","year":"2002","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C160","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.jacc.2009.01.053","article-title":"Benefits from small molecule administration as compared with abciximab among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-analysis","volume":"53","author":"De Luca","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C161","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/eurheartj\/ehp376","article-title":"Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"31","author":"Valgimigli","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C162","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jacc.2009.05.025","article-title":"The efficacy and safety of prasugrel with and without a glycoprotein IIb\/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis","volume":"54","author":"O'Donoghue","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C163","first-page":"511","article-title":"Catheter thrombosis during primary percutaneous coronary intervention for acute ST elevation myocardial infarction despite subcutaneous low-molecular-weight heparin, acetylsalicylic acid, clopidogrel and abciximab pretreatment","volume":"22","author":"Buller","year":"2006","journal-title":"Can J Cardiol"},{"key":"2026080919360214300_EHR236C164","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2009.03.062","article-title":"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb\/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial","volume":"54","author":"Jolly","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jacc.2008.05.036","article-title":"Safety and efficacy of bivalirudin with and without glycoprotein IIb\/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"52","author":"White","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C166","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jcin.2008.10.004","article-title":"Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"1","author":"Lincoff","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919360214300_EHR236C167","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ahj.2007.03.035","article-title":"Interactions between heparins, glycoprotein IIb\/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)","volume":"153","author":"Brieger","year":"2007","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C168","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C169","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1067\/mhj.2002.120299","article-title":"Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb\/IIIa receptor-directed platelet inhibition","volume":"143","author":"Li","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C170","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\u2018cooling-off\u2019 strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C171","doi-asserted-by":"crossref","first-page":"670S","DOI":"10.1378\/chest.08-0691","article-title":"Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Harrington","year":"2008","journal-title":"Chest"},{"key":"2026080919360214300_EHR236C172","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C173","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.jacc.2004.02.051","article-title":"A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study","volume":"43","author":"Simoons","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C174","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C175","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C176","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1161\/01.CIR.0000158485.70761.67","article-title":"Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) pilot trial","volume":"111","author":"Mehta","year":"2005","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C177","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1538-7836.2009.03705.x","article-title":"Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial","volume":"8","author":"Anderson","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2026080919360214300_EHR236C178","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C179","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1161\/01.CIR.100.15.1593","article-title":"Enoxaparin prevents death and cardiac ischemic events in unstable angina\/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial","volume":"100","author":"Antman","year":"1999","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C180","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJM199708143370702","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group","volume":"337","author":"Cohen","year":"1997","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C181","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(99)07350-X","article-title":"Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study","volume":"354","author":"FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators","year":"1999","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C182","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(96)91270-2","article-title":"Low-molecular-weight heparin during instability in coronary artery disease","volume":"347","author":"Fragmin during Instability in Coronary Artery Disease (FRISC) study group","year":"1996","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C183","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1378\/chest.126.3_suppl.188S","article-title":"Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Hirsh","year":"2004","journal-title":"Chest"},{"key":"2026080919360214300_EHR236C184","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0735-1097(97)00094-6","article-title":"Dose-ranging trial of enoxaparin for unstable angina: results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators","volume":"29","author":"TIMI 11A Investigators","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.CIR.0000136830.65073.C7","article-title":"Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin","volume":"110","author":"Montalescot","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C186","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(02)02531-7","article-title":"A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention","volume":"40","author":"Choussat","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C187","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/01.CIR.103.5.658","article-title":"Percutaneous coronary intervention after subcutaneous enoxaparin pretreatment in patients with unstable angina pectoris","volume":"103","author":"Collet","year":"2001","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C188","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","author":"Murphy","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C189","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.292.1.55","article-title":"Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial","volume":"292","author":"Blazing","year":"2004","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C190","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mhj.2002.126115","article-title":"Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin","volume":"144","author":"Cohen","year":"2002","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C191","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/01.CIR.0000050144.67910.13","article-title":"Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb\/IIIa inhibitor eptifibatide","volume":"107","author":"Goodman","year":"2003","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C192","first-page":"45","article-title":"Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial","volume":"292","author":"Ferguson","year":"2004","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C193","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.292.1.89","article-title":"Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview","volume":"292","author":"Petersen","year":"2004","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C194","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2125.2005.02452.x","article-title":"Anti-factor Xa kinetics after intravenous enoxaparin in patients undergoing percutaneous coronary intervention: a population model analysis","volume":"60","author":"Sanchez-Pena","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"2026080919360214300_EHR236C195","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1056\/NEJMoa052711","article-title":"Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention","volume":"355","author":"Montalescot","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C196","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C197","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(07)60450-4","article-title":"Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial investigators. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial","volume":"369","author":"Stone","year":"2007","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C198","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1001\/jama.298.21.2497","article-title":"Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial","volume":"298","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C199","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/j.jacc.2007.12.052","article-title":"Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"51","author":"White","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C200","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/CIRCULATIONAHA.108.832139","article-title":"Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial","volume":"119","author":"Alexander","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C201","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(09)60738-8","article-title":"Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial","volume":"374","author":"Mega","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C202","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/CIRCULATIONAHA.108.832139","article-title":"Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial","volume":"119","author":"Alexander","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C203","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0140-6736(09)61454-9","article-title":"Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial","volume":"374","author":"Sabatine","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C204","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/eurheartj\/ehq117","article-title":"Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and\/or undergoing coronary stenting: executive summary\u2014a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"31","author":"Lip","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C205","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.amjcard.2005.05.046","article-title":"In-hospital revascularization and one-year outcome of acute coronary syndrome patients stratified by the GRACE risk score","volume":"96","author":"Yan","year":"2005","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C206","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1001\/jama.293.23.2908","article-title":"Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C207","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C208","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O'Donoghue","year":"2008","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C209","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2009.1267","article-title":"Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial","volume":"302","author":"Montalescot","year":"2009","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C211","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0195-668X(03)00259-8","article-title":"A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b\/3a upstream therapy and acute coronary syndromes","volume":"24","author":"van't Hof AW, de Vries ST, Dambrink JH, Miedema K, Suryapranata H, Hoorntje JC, Gosselink AT, Zijlstra F, de Boer MJ","year":"2003","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C212","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C213","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","article-title":"Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes","volume":"32","author":"Katritsis","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C214","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/hrt.2008.154815","article-title":"Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes","volume":"95","author":"Riezebos","year":"2009","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C215","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.jacc.2009.11.063","article-title":"Impact of delay to angioplasty in patients with acute coronary syndromes undergoing invasive management: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"55","author":"Sorajja","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C216","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ahj.2007.09.007","article-title":"Culprit-only or multivessel revascularization in patients with acute coronary syndromes: an American College of Cardiology National Cardiovascular Database Registry report","volume":"155","author":"Brener","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C217","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jcin.2010.06.017","article-title":"Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial","volume":"3","author":"Ben-Gal","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919360214300_EHR236C218","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","article-title":"Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease","volume":"360","author":"Serruys","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C219","first-page":"219","article-title":"The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"2026080919360214300_EHR236C220","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1056\/NEJMoa044259","article-title":"Early invasive versus selectively invasive management for acute coronary syndromes","volume":"353","author":"de Winter RJ, Windhausen F, Cornel JH, Dunselman PH, Janus CL, Bendermacher PE, Michels HR, Sanders GT, Tijssen JG, Verheugt FW","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C221","doi-asserted-by":"crossref","first-page":"I467","DOI":"10.1161\/CIRCULATIONAHA.105.001420","article-title":"Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population","volume":"114","author":"Monteiro","year":"2006","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C222","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcin.2010.01.012","article-title":"Timing of in-hospital coronary artery bypass graft surgery for non-ST-segment elevation myocardial infarction patients results from the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines)","volume":"3","author":"Parikh","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"2026080919360214300_EHR236C223","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.athoracsur.2004.03.028","article-title":"Does clopidogrel increase blood loss following coronary artery bypass surgery?","volume":"78","author":"Chu","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"2026080919360214300_EHR236C224","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000081851","article-title":"The outcome of coronary artery bypass grafting surgery among patients hospitalized with acute coronary syndrome: the Euro Heart Survey of acute coronary syndrome experience","volume":"103","author":"Solodky","year":"2005","journal-title":"Cardiology"},{"key":"2026080919360214300_EHR236C225","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C226","first-page":"CD004587","article-title":"Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes","volume":"5","author":"Greenhalgh","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919360214300_EHR236C227","first-page":"937","article-title":"The feasibility and safety of routine thrombus aspiration in patients with non-ST-elevation myocardial infarction","volume":"72","author":"Vlaar","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"2026080919360214300_EHR236C228","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/eurheartj\/ehi774","article-title":"Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey","volume":"27","author":"Rosengren","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C229","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1093\/eurheartj\/ehm464","article-title":"Effect of an invasive strategy on in-hospital outcome in elderly patients with non-ST-elevation myocardial infarction","volume":"28","author":"Bauer","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C230","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1161\/CIRCULATIONAHA.107.182615","article-title":"Acute coronary care in the elderly, part I: non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology","volume":"115","author":"Alexander","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C231","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1001\/jama.294.24.3108","article-title":"Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C232","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/eurheartj\/ehn236","article-title":"Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial","volume":"29","author":"Lopes","year":"2008","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C233","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(00)02427-2","article-title":"Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease","volume":"356","author":"Wallentin","year":"2000","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C234","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(06)69416-6","article-title":"Wallentin L. 5-Year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study","volume":"368","author":"Lagerqvist","year":"2006","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C235","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-141-3-200408030-00007","article-title":"The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes","volume":"141","author":"Bach","year":"2004","journal-title":"Ann Intern Med"},{"key":"2026080919360214300_EHR236C236","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ehj.2004.02.023","article-title":"Sex, age, and clinical presentation of acute coronary syndromes","volume":"25","author":"Rosengren","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C237","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/hrt.2006.102012","article-title":"Gender differences in management and outcome in non-ST-elevation acute coronary syndrome","volume":"93","author":"Alfredsson","year":"2007","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C238","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehp493","article-title":"Women with acute coronary syndrome are less invasively examined and subsequently less treated than men","volume":"31","author":"Hvelplund","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C239","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2010.04.017","article-title":"Gender differences in time to presentation for myocardial infarction before and after a national women's cardiovascular awareness campaign: a temporal analysis from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress ADverse Outcomes with Early Implementation (CRUSADE) and the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get with the Guidelines (NCDR ACTION Registry-GWTG)","volume":"160","author":"Diercks","year":"2010","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.amjcard.2006.01.072","article-title":"Gender differences in acute non-ST-segment elevation myocardial infarction","volume":"98","author":"Heer","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C241","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.amjcard.2003.12.019","article-title":"Invasive therapy along with glycoprotein IIb\/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: a meta-analysis and review of the literature","volume":"93","author":"Bavry","year":"2004","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C242","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(02)09894-X","article-title":"Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina","volume":"360","author":"Fox","year":"2002","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C243","first-page":"CD004815","article-title":"Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era","volume":"3","author":"Hoenig","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919360214300_EHR236C244","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1001\/jama.288.24.3124","article-title":"Benefit of an early invasive management strategy in women with acute coronary syndromes","volume":"288","author":"Glaser","year":"2002","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C245","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0140-6736(02)09532-6","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes","volume":"360","author":"Boersma","year":"2002","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C246","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jama.2009.1227","article-title":"Sex differences in mortality following acute coronary syndromes","volume":"302","author":"Berger","year":"2009","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C247","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.ehj.2004.09.021","article-title":"Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction","volume":"25","author":"Bartnik","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C248","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1111\/j.1464-5491.2005.01696.x","article-title":"Diabetes mellitus: clinical presentation and outcome in men and women with acute coronary syndromes. Data from the Euro Heart Survey ACS","volume":"22","author":"Dotevall","year":"2005","journal-title":"Diabet Med"},{"key":"2026080919360214300_EHR236C249","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.298.7.765","article-title":"Diabetes and mortality following acute coronary syndromes","volume":"298","author":"Donahoe","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C250","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.amjcard.2008.11.034","article-title":"Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus","volume":"103","author":"Hasin","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C251","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/eurheartj\/ehq162","article-title":"Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options","volume":"31","author":"De Caterina","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C252","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/eurheartj\/ehm316","article-title":"European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)","volume":"28","author":"Graham","year":"2007","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C253","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C254","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1001\/jama.298.20.2399","article-title":"Glucose\u2013insulin\u2013potassium therapy in patients with ST-segment elevation myocardial infarction","volume":"298","author":"Diaz","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C255","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C256","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","article-title":"Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials","volume":"373","author":"Hlatky","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C257","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C258","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C259","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2009.09.057","article-title":"Diabetic and nondiabetic patients with left main and\/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents","volume":"55","author":"Banning","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C260","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa071804","article-title":"Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease","volume":"358","author":"Hannan","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C261","doi-asserted-by":"crossref","first-page":"a1331","DOI":"10.1136\/bmj.a1331","article-title":"Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis","volume":"337","author":"Stettler","year":"2008","journal-title":"BMJ"},{"key":"2026080919360214300_EHR236C262","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.108.791061","article-title":"Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38","volume":"118","author":"Wiviott","year":"2008","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C263","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/eurheartj\/ehq325","article-title":"Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"31","author":"James","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C264","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1161\/hc4801.100029","article-title":"Platelet glycoprotein IIb\/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes","volume":"104","author":"Roffi","year":"2001","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C265","first-page":"CD002967","article-title":"Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus","volume":"4","author":"Salpeter","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919360214300_EHR236C266","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","article-title":"A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS)","volume":"23","author":"Hasdai","year":"2002","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C267","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archinternmed.2010.95","article-title":"Relation between renal function and outcomes in patients with non-ST-segment elevation acute coronary syndrome: real-world data from the European Public Health Outcome Research and Indicators Collection Project","volume":"170","author":"Goldenberg","year":"2010","journal-title":"Arch Intern Med"},{"key":"2026080919360214300_EHR236C268","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J Intern Med"},{"key":"2026080919360214300_EHR236C269","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehi337","article-title":"Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb\/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events","volume":"26","author":"Collet","year":"2005","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C270","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-147-5-200709040-00005","article-title":"Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes","volume":"147","author":"Fox","year":"2007","journal-title":"Ann Intern Med"},{"key":"2026080919360214300_EHR236C271","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.109.933796","article-title":"Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"122","author":"James","year":"2010","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C272","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1001\/jama.295.23.2765","article-title":"Prophylaxis strategies for contrast-induced nephropathy","volume":"295","author":"Pannu","year":"2006","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C273","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1161\/CIRCULATIONAHA.108.838169","article-title":"Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"120","author":"Szummer","year":"2009","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C274","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C275","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehq337","article-title":"2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association","volume":"31","author":"Dickstein","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C276","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C277","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C278","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C279","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ahj.2005.09.024","article-title":"The obesity paradox in non-ST-segment elevation acute coronary syndromes: results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology\/American Heart Association Guidelines Quality Improvement Initiative","volume":"152","author":"Diercks","year":"2006","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C280","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.amjcard.2007.06.019","article-title":"Medical therapies and invasive treatments for coronary artery disease by body mass: the \u2018obesity paradox\u2019 in the Get With The Guidelines database","volume":"100","author":"Steinberg","year":"2007","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C281","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2010.08.626","article-title":"3-Year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up","volume":"57","author":"Ong","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C282","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.amjcard.2009.03.066","article-title":"Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction","volume":"104","author":"Hasin","year":"2009","journal-title":"Am J Cardiol"},{"key":"2026080919360214300_EHR236C283","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/eurheartj\/ehp401","article-title":"Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes","volume":"31","author":"Bassand","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C284","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/hrt.2007.136390","article-title":"Association of the arterial access site at angioplasty with transfusion and mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg)","volume":"94","author":"Chase","year":"2008","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C285","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jacc.2004.04.034","article-title":"Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials","volume":"44","author":"Agostoni","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C286","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ahj.2008.01.009","article-title":"Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes","volume":"155","author":"Alexander","year":"2008","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C287","first-page":"CD002042","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"2","author":"Hill","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080919360214300_EHR236C288","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium (BARC)","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C289","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/eurheartj\/ehp499","article-title":"Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C290","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C291","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/eurheartj\/ehn358","article-title":"Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes","volume":"30","author":"Budaj","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C292","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehp110","article-title":"Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial","volume":"30","author":"Mehran","year":"2009","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C293","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2008.04.002","article-title":"Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis","volume":"51","author":"Antman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026080919360214300_EHR236C294","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","article-title":"Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial","volume":"121","author":"Berger","year":"2010","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C295","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"Sorensen","year":"2009","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C296","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ahj.2008.10.028","article-title":"Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk","volume":"157","author":"Joyner","year":"2009","journal-title":"Am Heart J"},{"key":"2026080919360214300_EHR236C297","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/CIRCULATIONAHA.107.694273","article-title":"Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?","volume":"116","author":"Spencer","year":"2007","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C298","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.292.13.1555","article-title":"Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes","volume":"292","author":"Rao","year":"2004","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C299","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/CIRCULATIONAHA.109.853135","article-title":"Minimizing the risks of anticoagulants and platelet inhibitors","volume":"121","author":"Alexander","year":"2010","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C300","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1001\/jama.2010.708","article-title":"Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention","volume":"303","author":"Marso","year":"2010","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C301","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications","volume":"154","author":"Yank","year":"2011","journal-title":"Ann Intern Med"},{"key":"2026080919360214300_EHR236C302","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199902113400601","article-title":"A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group","volume":"340","author":"Hebert","year":"1999","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C303","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C304","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1185\/030079908X261096","article-title":"One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database","volume":"24","author":"Menzin","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"2026080919360214300_EHR236C305","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1161\/CIRCULATIONAHA.106.174516","article-title":"AHA\/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C306","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","article-title":"Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes","volume":"121","author":"Chow","year":"2010","journal-title":"Circulation"},{"key":"2026080919360214300_EHR236C307","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/hrt.2009.174276","article-title":"Potential survival gains in the treatment of myocardial infarction","volume":"95","author":"Chew","year":"2009","journal-title":"Heart"},{"key":"2026080919360214300_EHR236C308","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C309","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(06)69201-5","article-title":"Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials","volume":"368","author":"Dagenais","year":"2006","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C310","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archinte.166.7.787","article-title":"Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials","volume":"166","author":"Danchin","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026080919360214300_EHR236C311","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C312","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.166.17.1814","article-title":"The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials","volume":"166","author":"Hulten","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026080919360214300_EHR236C313","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C314","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","article-title":"Expert consensus document on beta-adrenergic receptor blockers","volume":"25","author":"Lopez-Sendon","year":"2004","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C315","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C316","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)09374-X","article-title":"Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation","volume":"354","author":"Torp-Pedersen","year":"1999","journal-title":"Lancet"},{"key":"2026080919360214300_EHR236C317","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"2026080919360214300_EHR236C318","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999\u20132006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"2026080919360214300_EHR236C319","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"2026080919360214300_EHR236C320","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/eurheartj\/ehl100","article-title":"Incidence, time course, and predictors of early malignant ventricular arrhythmias after non-ST-segment elevation myocardial infarction in patients with early invasive treatment","volume":"27","author":"Rahimi","year":"2006","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/32\/23\/2999\/70578851\/eurheartj_32_23_2999.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/32\/23\/2999\/70578851\/eurheartj_32_23_2999.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:36:46Z","timestamp":1786318606000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/32\/23\/2999\/477824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,26]]},"references-count":320,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2011,8,26]]},"published-print":{"date-parts":[[2011,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehr236","relation":{},"ISSN":["1522-9645","0195-668X"],"issn-type":[{"value":"1522-9645","type":"electronic"},{"value":"0195-668X","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,12]]},"published":{"date-parts":[[2011,8,26]]}}}